Immunoglobulin G
Pain Medicine: An Essential Review, Page: 185-186
2017
- 100Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Captures100
- Readers100
- 100
Book Chapter Description
Immunoglobulin G (IgG) concentrates are immune-modulating, anti-inflammatory human blood plasma-derived products that can be used for the treatment of some peripheral neuropathies and a range of other pain disorders. While evidence is still emerging, IgG is a relatively safe but expensive, therapeutic strategy for chronic pain conditions.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85032977061&origin=inward; http://dx.doi.org/10.1007/978-3-319-43133-8_51; http://link.springer.com/10.1007/978-3-319-43133-8_51; http://link.springer.com/content/pdf/10.1007/978-3-319-43133-8_51; https://dx.doi.org/10.1007/978-3-319-43133-8_51; https://link.springer.com/chapter/10.1007/978-3-319-43133-8_51
Springer Nature
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know